Managing Your Shipping of Emergency Medicines

Managing Your Shipping Of Emergency Medicines

Due to the persisting COVID-19 pandemic, pharma supply chains are disrupted worldwide and many have been brought to a halt. Besides re-visiting risk assessment and building strategies, the pharma industry can learn valuable lessons from this crisis. As part of the Corona360 – In Conversation series, the Managing Your Shipping of Emergency Medicines live moderation aims to discuss cases and future plans coping with unpredicted schedules, increased timelines and optimize costs so that companies will be well-equipped to address additional waves or a post-pandemic scenario where SARS-CoV-2 continues to circulate as a seasonal virus.

Interview Details

4th June 2020, Thursday

10:30:00 (GMT +8:00)

Register Now

Add to Calendar

  • Big Pharma, Asian Pharma, Bio Pharma, Airlines, 3PL’s, Temperature/Data logger, Packaging (active & passive), Distributor, CRO 
  • C-Suites, Supply chain / Logistics / Quality job profiles
  • Due to the global lock-down, the shipping of emergency medicines etc have been disrupted.
  • How is the supply chain industry managing the shipping of emergency drugs especially cold-chain products?
  • Strategies for handling unpredictable schedules, increased timelines and optimize costs.

Meet Our Panelists

Geoffrey Glauser, Sr. Consultant, Tunnell Consulting, USA

Jeff Ten, Director (APAC) Project Management and Delivery & Logistics, Parexel, Singapore

Christophe Suizdak, Global Director of Supply Chain GE Healthcare France

Key Discussion Points

Managing Your Shipping of Emergency Medicines

  • Due to the global lock-down, challenges of the shipping of emergency medicines
  • Supply chain management of temperature sensitive emergency medicines in the global market
  • Strategies for handling unpredictable schedules, increased timelines and optimize costs

Market Intelligence